Noll L. Campbell
Research scientist
Centre for aging research
Regenstrief Institute
United States of America
Biography
Dr. Campbell has completed his Doc of Pharmacy, from Butler University in 2002.As an aging brain pharmacoepidemiologist he is most interested in the impact medications may have on the development or progression of cognitive dysfunction. This work extends to both the acute care (Pharmacologic Management of Delirium, PMD study) and ambulatory environments (COMET-AD, comparative effectiveness study in Alzheimer’s Disease).
Research Interest
Dr. Campbell’s interest is in medication management of older adults with cognitive impairment.
Publications
-
Campbell NL, Perkins AJ, Bradt P, Perk S, Wielage RC et al (2016) Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population.Pharmacotherapy 36: 1123-1131.
-
Khan BA, Perkins AJ, Gao S, Hui SL, Campbell NL et al (2017) The Confusion Assessment Method for the ICU-7 Delirium Severity Scale: A Novel Delirium Severity Instrument for Use in the ICU. Crit Care Med 45: 851-857.
